MD SB312 | 2019 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 7-0)
Status: Introduced on January 30 2019 - 25% progression
Action: 2019-02-11 - Hearing 3/06 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Prohibiting an insurer, based solely on information about the purchase or possession of an opioid overdose reversal drug by an applicant or insured or a prescription for an opioid overdose reversal drug prescribed to an applicant or insured, from taking certain actions relating to a policy of life insurance; and applying the Act to life insurance policies issued, delivered, or renewed in the State on or after January 1, 2020.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Life Insurance - Prohibition on Discrimination - Opioid Overdose Reversal Drug

Sponsors


History

DateChamberAction
2019-02-11SenateHearing 3/06 at 1:00 p.m.
2019-01-30SenateFirst Reading Finance

Subjects


Maryland State Sources


Bill Comments

feedback